UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020251
Receipt No. R000023381
Official scientific title of the study Internal organs fat decrease effect confirmation examination in long-term aging vinegar "KOZU" (Double-blind study)
Date of disclosure of the study information 2016/01/10
Last modified on 2016/11/01 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Internal organs fat decrease effect confirmation examination in long-term aging vinegar "KOZU" (Double-blind study)
Title of the study (Brief title) Internal organs fat decrease effect confirmation examination in vinegar "KOZU" (NKJ-1 study)
Region
Japan

Condition
Condition BMI value is higher Japanese
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To target a monitor that is definition and BMI increased , to confirm the effect of reducing visceral fat when it is allowed to continue ingestion of the test substance
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Visceral fat area of the abdomen (Intervention before 4 weeks , before the start , after 12 weeks)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 The subjects(long-term aged vineger"KOZU") eat 15mL/day for 12 weeks
Interventions/Control_2 The subjects(short-term aged vineger"KOZU") eat 15mL/day for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
60 years-old >=
Gender Male and Female
Key inclusion criteria 1)The healthy person who does not have a serious disease
2)And wish to voluntarily participate in a clinical trial following 60 years of age or 30 years of age , who written consent is obtained
3)Who can ingest the vinegar
4)BMI (Body Mass Index) of 23 or more , of less than 30 persons
5)Who can maintain the daily life weekly during the test period at a constant
Key exclusion criteria 1)Diabetes, heart disease, kidney disease, liver disease, those who have a medication for the treatment of hypertension such as
2)Severe disease (cancer, heart disease, kidney disease, etc.) A person with a history of
3)A person more than three times the reference value upper limit of liver function and renal function test values
4)Persons with food allergies and drug allergy related to the food test
5)Those who have had surgery of the digestive tract
6)Those who have regular specified health food and functional food display related to the cholesterol blood sugar suppress and bowel movement improvement (indigestible dextrin, plant sterols, chitosan, those including psyllium seed coat) a
7)Those persons and in the diet to the violent sport
8)Those who are participating in other clinical trials within the past one month
9)Hot flashes, dizziness, there are subjective symptoms of menopause symptoms of sweating like a person
10)Persons under postmenopausal three years
11)Who you are wearing a pacemaker
12)Those who participate in the study investigator were disqualified
Target sample size 40

Research contact person
Name of lead principal investigator Hiromu Katsuta
Organization Relife-inc
Division name Clinical Development Division
Address Koshin BLD 501 1-47-1 Higashi-Ikebukuro Toshima-ku Tokyo
TEL 03-5928-2501
Email hkatsuta@relife-inc.com

Public contact
Name of contact person Hiromu Katsuta
Organization Relife-inc
Division name Clinical Development Division
Address Koshin BLD 501 1-47-1 Higashi-Ikebukuro Toshima-ku Tokyo
TEL 03-5928-2501
Homepage URL
Email hkatsuta@relife-inc.com

Sponsor
Institute Kojun Japan co.,ltd.
Institute
Department

Funding Source
Organization Kojun Japan co.,ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 01 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 30 Day
Anticipated trial start date
2016 Year 01 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 17 Day
Last modified on
2016 Year 11 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023381